Sanegene Bio
Sanegene Bio develops an RNAi drug discovery platform designed for unmet clinical needs.
About Sanegene Bio
Sanegene Bio develops an RNAi drug discovery platform designed for unmet clinical needs. Its RNAi portfolio covers a broad range of therapeutic areas including cardiovascular and metabolic diseases, immunology-related diseases, and nervous system diseases
Company Facts
- Headquarters
- Woburn
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00051_00100
- Funding Stage
- early_stage_venture
- Total Funding
- $240,000,000
- Last Funding Type
- series_b
- Last Funding Date
- 2025-12-08
- Website
- sanegenebio.com
Industries & Categories
Biopharma, Health Care, Medical, Therapeutics
Social Links
Canonical: https://fsome.com/organization/sanegene-bio-30938 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.